	US 12,138,294 B2
	Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
Jesse M. Jaynes, Auburn, AL (US); Kanniah Rajasekaran, Metairie, LA (US); Jeffrey W. Cary, Covington, LA (US); Ronald Sayler, Farmington, AR (US); and Rajtilak Majumdar, Metairie, LA (US)
Assigned to GENVOR INC., Chapel Hill, NC (US); and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, Washington, DC (US)
Filed by GENVOR, INC., Dallas, TX (US); and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, Washington, DC (US)
Filed on Jul. 3, 2023, as Appl. No. 18/346,317.
Application 18/346,317 is a continuation of application No. 17/352,445, filed on Jun. 21, 2021, granted, now 11,690,894.
Application 17/352,445 is a continuation of application No. 16/134,336, filed on Sep. 18, 2018, granted, now 11,083,775, issued on Aug. 10, 2021.
Prior Publication US 2024/0033324 A1, Feb. 1, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/82 (2006.01); A61K 38/17 (2006.01)

CPC A61K 38/1767 (2013.01) [C12N 15/8205 (2013.01); C12N 15/8216 (2013.01); C12N 15/8282 (2013.01)]

20 Claims

1. A transgenic maize line expressing a synthetic AGM182 peptide, wherein the transgenic maize line is made by the method comprising the steps of:

introducing into immature maize embryos by agrobacterium-mediated transformation the synthetic AGM182 gene, wherein the AGM182 gene comprises a 129 bp nucleic acid of SEQ ID NO:3.